English | Español
Jeff Gantt | Dec 24, 2016

Energy and Commerce Committee sees three bills signed into law
Jeff Gantt | Dec 24, 2016

Novartis announces acquisition of Ziarco
Jeff Gantt | Dec 24, 2016

ANVISA approves Belviq in Brazil
Jeff Gantt | Dec 24, 2016

Pfizer releases Paloma-2 sub-analysis study data
Jeff Gantt | Dec 24, 2016

European Commission approves Nimenrix for meningococcal disease
Keri Carbaugh | Dec 24, 2016

Pfizer’s Ibrance application accepted by FDA
Keri Carbaugh | Dec 24, 2016

Sucampo proposes making convertible senior notes available
Jeff Gantt | Dec 24, 2016

EMA recommends Keytruda for approval

Trending
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Mark Cuban on PBMs: ‘Patients are getting ripped off because PBMs and wholesalers insist on using inflated list prices'
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment